PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines

Background: The US Food and Drug Administration (FDA) has approved several immunotherapeutic drugs for cancer since 2010, and many more are still being evaluated in other clinical studies. These inhibitors significantly increase response rates and result in the treatment of patients with advanced ca...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mohammed Safi, Hyat Ahmed, Mahmoud Al-Azab, Yun-long Xia, Xiu Shan, Mohammed Al-radhi, Abdullah Al-danakh, Abdullah Shopit, Jiwei Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2021-03-01
Edice:	Journal of Advanced Research
Témata:	PD-1 PDL-1 Cardiotoxicity Myocarditis Heart block
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2090123220302150
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!